Profit Margin (Quarterly)

Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues

Escalon Medical Corp. (ESMC) had Profit Margin of 3.90% for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$3.47M
Net Income	$0.14M
Cost of Goods Sold	$1.87M
Gross Profit	$1.60M
Operating Expenses	$3.20M
Operating Income	$0.28M
Non-Operating Income/Expense	$-0.00M
Pre-Tax Income	$0.27M
Normalized Pre-Tax Income	$0.27M
Income after Taxes	$0.27M
Income from Continuous Operations	$0.27M
Consolidated Net Income/Loss	$0.27M
Normalized Income after Taxes	$0.27M
EBIT	$0.28M
EBITDA	$0.28M
Weighted-Average Shares Outstanding (Basic)	7.42M
Weighted-Average Shares Outstanding (Diluted)	14.17M
Earnings per Share (EPS) (Basic)	$0.02
Earnings per Share (EPS) (Diluted)	$0.02
Balance Sheet Financials
Current Assets	$4.84M
Property, Plant, and Equipment	$0.03M
Long-Term Assets	$0.41M
Total Assets	$5.22M
Current Liabilities	$2.52M
Long-Term Debt	$0.23M
Long-Term Liabilities	$0.40M
Total Liabilities	$2.92M
Common Equity	$1.65M
Tangible Shareholders Equity	$2.23M
Shareholders Equity	$2.29M
Common Shares Outstanding	7.42M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$0.36M
Cash Flow from Investing Activities	$0.00M
Cash Flow from Financial Activities	$-0.03M
Beginning Cash	$0.47M
End Cash	$0.80M
Increase/Decrease in Cash	$0.33M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.92
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.09
Debt to Equity Ratio	0.12
Gross Margin	46.05%
Operating Margin	7.95%
EBIT Margin	7.95%
EBITDA Margin	--
Pre-Tax Profit Margin	7.81%
Profit Margin	3.90%
Free Cash Flow	$0.36M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.67
Inventory Turnover	1.07
Receiveable Turnover	1.63
Days Sales in Receivables	55.15
Return on Equity	16.45%
Return on Tangible Equity	12.20%
Return on Assets	5.21%
Return on Investments	10.74%
Book Value Per Share	$0.31
Free Cash Flow per Share	$0.03
Operating Cash Flow per Share	$0.03

Data from Zacks Investment Research, Inc.